CompletedNCT00003793
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
Studying Embryonal rhabdomyosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Stella M. Davies, MBBS, PhD, MDPhDChildren's Hospital Medical Center, Cincinnati
- Intervention
- clonality analysis(genetic)
- Enrollment
- 294 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 1998 – 2007
Study locations (30)
- Southern California Permanente Medical Group, Downey, California, United States
- Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California, United States
- Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
- Children's Hospital Central California, Madera, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Stanford Comprehensive Cancer Center at Stanford University Medical Center, Stanford, California, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, United States
- Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System, Fort Myers, Florida, United States
- University of Florida Shands Cancer Center, Gainesville, Florida, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- Miami Children's Hospital, Miami, Florida, United States
- Baptist-South Miami Regional Cancer Program, Miami, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003793 on ClinicalTrials.govOther trials for Embryonal rhabdomyosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07054944Tumor-Lymph Node MappingUniversity of Rochester
- RECRUITINGPHASE1, PHASE2NCT06541262Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsMilton S. Hershey Medical Center
- RECRUITINGPHASE1NCT04337177Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsValent Technologies, LLC